Literature DB >> 25027402

Clinical significance of serum ferritin in elderly patients with primary lung carcinoma.

Mei Ji1, Xiao-Dong Li, Hong-Bing Shi, Zhong-Hua Ning, Wei-Qing Zhao, Qi Wang, Li-Na Zhu, Yan Liu, Chang-Ping Wu.   

Abstract

This study determined the levels of serum ferritin (SF) and carcinoembryonic antigen (CEA) in elderly patients with advanced primary lung cancer (PLC), and aimed to investigate the correlation between the SF level and clinical characteristics and compare the positive rates of SF and CEA levels in PLC patients and those in normal subjects. The SF and CEA levels of 69 elderly cases of advanced PLC and 63 elderly controls were determined by electrochemiluminescence method. The correlation between each independent clinicopathological characteristic and levels of SF and CEA was calculated. The positive rates of SF and CEA levels in PLC patients and those in normal subjects were compared. The results revealed that the level of SF in controls was significantly lower than those in patients with advanced LC (145.04 ± 141.77 vs. 293.57 ± 274.95 ng/ml, t = -3.845, P = 0.000). There was a statistically significant difference between SF level and gender, smoking, and regional lymph node metastasis, respectively (P < 0.05). The positive rate of SF combining with CEA was significantly higher than those of SF and CEA alone in patients with advanced PLC. High serum level of SF is helpful for diagnosing PLC in elderly patients and indicates poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027402     DOI: 10.1007/s13277-014-2317-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy.

Authors:  Tolia G Maria; Kouloulias E Vasileios; Pantelakos S Panagiotis; Syrigos N Kostas
Journal:  Int J Clin Exp Med       Date:  2012-11-18

2.  Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.

Authors:  Z Kirkali; M Güzelsoy; M U Mungan; G Kirkali; K Yörükoglu
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

3.  Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.

Authors:  Masayoshi Inoue; Masato Minami; Hiroyuki Shiono; Noriyoshi Sawabata; Kan Ideguchi; Meinoshin Okumura
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

Review 4.  Serum ferritin: Past, present and future.

Authors:  Wei Wang; Mary Ann Knovich; Lan G Coffman; Frank M Torti; Suzy V Torti
Journal:  Biochim Biophys Acta       Date:  2010-03-19

5.  CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.

Authors:  Thomas Muley; Hendrik Dienemann; Werner Ebert
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

6.  Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Tsuyoshi Yuki; Akio Nakagawa; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

7.  Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.

Authors:  Yukinori Sakao; Shinji Tomimitsu; Yuji Takeda; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

8.  Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer.

Authors:  Suzana Kukulj; Morana Jaganjac; Milivoj Boranic; Simun Krizanac; Zarko Santic; Marija Poljak-Blazi
Journal:  Med Oncol       Date:  2009-03-24       Impact factor: 3.064

9.  Tissue ferritin concentration in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

10.  Serum ferritin in colorectal cancer patients and its prognostic evaluation.

Authors:  M Lorenzi; B Lorenzi; R Vernillo
Journal:  Int J Biol Markers       Date:  2006 Oct-Dec       Impact factor: 3.248

View more
  9 in total

1.  High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer.

Authors:  Hong Tingting; Shen Di; Chen Xiaoping; Wu Xiaohong; Hua Dong
Journal:  Saudi Med J       Date:  2017-03       Impact factor: 1.484

2.  The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing.

Authors:  Nikolaos P E Kadoglou; Jane P Biddulph; Snorri B Rafnsson; Marialena Trivella; Petros Nihoyannopoulos; Panayotes Demakakos
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

3.  Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer.

Authors:  Xijuan Wang; Peng An; Jiling Zeng; Xiaoyan Liu; Bo Wang; Xuexian Fang; Fudi Wang; Guoping Ren; Junxia Min
Journal:  Oncotarget       Date:  2017-03-14

4.  Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.

Authors:  Anna Song; Wankyu Eo; Sehyun Kim; Bumsang Shim; Sookyung Lee
Journal:  BMC Complement Altern Med       Date:  2018-06-07       Impact factor: 3.659

5.  Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer.

Authors:  Sookyung Lee; Wankyu Eo; Hyeonjin Jeon; Sora Park; Jean Chae
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

6.  Reduction in Ferritin Concentrations among Patients Consuming a Dark-Green Leafy Vegetable-Rich, Low Inflammatory Foods Everyday (LIFE) Diet.

Authors:  Brittany M Perzia; Gui-Shuang Ying; Joshua L Dunaief; David M Dunaief
Journal:  Curr Dev Nutr       Date:  2022-05-18

7.  Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence.

Authors:  Grzegorz Mariusz Sukiennicki; Wojciech Marciniak; Magdalena Muszyńska; Piotr Baszuk; Satish Gupta; Katarzyna Białkowska; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Marcin Lener; Sandra Pietrzak; Tomasz Gromowski; Karolina Prajzendanc; Alicja Łukomska; Piotr Waloszczyk; Janusz Zenon Wójcik; Rodney Scott; Jan Lubiński; Anna Jakubowska
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

Review 8.  Iron Metabolism in Cancer Progression.

Authors:  Stefania Forciniti; Luana Greco; Fabio Grizzi; Alberto Malesci; Luigi Laghi
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

Review 9.  [Mechanism of Ferroptosis and Its Research Progress in Lung Cancer].

Authors:  Jinming Wu; Lifang Ma; Jiayi Wang; Yongxia Qiao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.